Previous scRNA-seq studies have shown that the heterogeneity of the MYC family carried by ecDNA across different tumor cells significantly influences cellular transcriptional programs in neuroblastoma, small-cell lung cancer, and pancreatic ductal adenocarcinoma2,8,9. The gene discussed is MYC; the disease is neoplasm.